Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008;3(2):251-62.
doi: 10.2147/cia.s1794.

Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems

Randi J Hagerman  1 , Deborah A Hall, Sarah Coffey, Maureen Leehey, James Bourgeois, John Gould, Lin Zhang, Andreea Seritan, Elizabeth Berry-Kravis, John Olichney, Joshua W Miller, Amy L Fong, Randall Carpenter, Cathy Bodine, Louise W Gane, Edgar Rainin, Hillary Hagerman, Paul J Hagerman
Affiliations
Review

Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems

Randi J Hagerman et al. Clin Interv Aging. 2008.

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive neurological disorder that affects older adult carriers, predominantly males, of premutation alleles (55 to 200 CGG repeats) of the fragile X (FMR1) gene. Principal features of FXTAS are intention tremor, ataxia, parkinsonism, cognitive decline, and peripheral neuropathy; ancillary features include, autonomic dysfunction, and psychiatric symptoms of anxiety, depression, and disinhibition. Although controlled trials have not been carried out in individuals with FXTAS, there is a significant amount of anecdotal information regarding various treatment modalities. Moreover, there exists a great deal of evidence regarding the efficacy of various medications for treatment of other disorders (eg, Alzheimer disease) that have substantial phenotypic overlap with FXTAS. The current review summarizes what is currently known regarding the symptomatic treatment, or potential for treatment, of FXTAS.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adams J, Adams P, Nguyen D, et al. Volumetric brain changes in males and females with the fragile X associated tremor/ataxia syndrome (FXTAS) Neurology. 2007;69:851–9. - PubMed
    1. Aggarwal NT, Wilson RS, Beck TL, et al. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol. 2006;63:1763–9. - PubMed
    1. Alexopoulos GS, Kiosses DN, Heo M, et al. Executive dysfunction and the course of geriatric depression. Biol Psychiatry. 2005;58:204–10. - PubMed
    1. Alexopoulos GS, Raue P, Areán P. Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. Am J Geriatr Psychiatry. 2003;11:46–52. - PubMed
    1. Alpert JE, Fava M. Nutrition and depression: the role of folate. Nutr Rev. 1997;55:145–9. - PubMed

Publication types

Substances

LinkOut - more resources